A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia
Condition: Friedreich Ataxia Interventions: Biological: CTI-1601; Other: Placebo Sponsor: Larimar Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials